Most Popular Angioplasty Web Site
    Radial Center on Angioplasty.Org Radial Center on Angioplasty.Org with support from Medtronic Cardiovascular
Terumo Interventional Systems First To Offer Multiple, All-In-One Radial Access Kits For Double Or Single-Wall Entry Sticks

Glidesheath Nitinol Kit     November 16, 2010 -- Somerset, New Jersey -- Terumo Interventional Systems, a strategic business unit of Terumo Medical Corporation, and leading manufacturer and distributor of guidewires, catheters, sheaths, and embolization products, today announced the nationwide availability of the new Glidesheath™ Nitinol Kit, an all-in-one, micro-puncture radial access kit for physicians who prefer transradial interventional procedures.  

The new all-in-one Glidesheath Nitinol Kit expands the product family portfolio and is available with unique features such as a new .021” nitinol floppy palladium-tipped wire and a 21 gauge metal needle. Unlike competitive kits that do not have a hydrophilic sheath , each Glidesheath Nitinol Kit includes everything the operator will need in one complete, convenient package.

"Terumo now offers a wide variety of specialized radial access kits to meet everyone’s needs for managing access from the radial artery. We are pleased to offer the new Glidesheath Nitinol Kit as an all-in-one solution for transradial procedures," said Gary Clifton, Senior Marketing Manager, Terumo Medical Corporation. "This product expansion is another milestone in our commitment to delivering a complete set of radial access tools that will enhance successful outcomes and quality of life for patients."

Glidesheath Hydrophilic Coated Introducer Sheaths offer the full-length Terumo Glide Technology™ coating to ensure smooth, atraumatic insertion and removal even in the most difficult procedures. The Glidesheath’s unique design provides optimal flexibility for kink resistance to ensure an open lumen throughout the procedure, while the cross-cut valve allows for easy insertion of catheters and devices, while offering uncompromised hemostasis.

Transradial access uses the arteries of the wrist, rather than the groin, to gain access to the heart. It is the leading access strategy in many countries of the world and while the technique accounts for an estimated three to five percent of cases in the U.S., there is a growing interest among physicians for more specialized tools that facilitate the procedure.

For more information about the new Glidesheath Nitinol Kit, please call 800-862-4143 to speak with an Inside Sales Specialist or visit

Terumo Interventional Systems
Terumo Interventional Systems (TIS), a strategic business unit of Terumo Medical Corporation, directly markets a full line of guidewires, catheters, introducer sheaths, guiding sheaths and embolization products for use in a multitude of different interventional procedures.

Interventional Radiologists, Interventional Neuroradiologists, Interventional Cardiologists, and Vascular Surgeons are among the medical professionals that depend upon TIS products to access and cross difficult-to-reach lesions, thereby allowing therapeutic intervention in previously unreachable vascular beds.

Terumo Medical Corporation
Founded in 1972 as a Terumo Corporation subsidiary, Terumo Medical Corporation (TMC) develops, manufactures, and markets high-quality medical devices used in a broad range of applications in numerous healthcare markets. TMC manufactures a broad portfolio of needles and syringes, entry-site management products, and a line of sterile connection devices used in hospitals and blood banks worldwide.

Terumo Corporation
Tokyo-based Terumo Corporation is one of the world’s leading medical device manufacturers with $3.0 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures, and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures, and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the healthcare market and by responding to the needs of healthcare providers and the people they serve.

Terumo Corporation’s shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan’s leading stock index.

Source: Terumo Interventional Systems